GB Sciences Inc (GBLX)

[Supermeatball]

GB Sciences is Happy
Mr. Kevin Kuethe has been appointed COO of GB Sciences. The company is happy, the plants are happy, the customers are happy, and the shareholders should definitely be happy.

November 13, 2017 05:30 ET | Source: GB Sciences, Inc.

photo-release

Image from an interview with GB Sciences COO Kevin Kuethe

Las Vegas, NV, Nov. 13, 2017 (GLOBE NEWSWIRE) -- GB Sciences, Inc. (OTCQB: GBLX) announces that it has met the October gross revenue projection of $500K from the sale of premium flower. Gross sales projections for the month of November are also trending in this direction.

CLICK HERE TO WATCH VIDEO

With reported gross sales of only $320K in the last financial quarter, how did this drastic turnaround occur? This question was posed to newly appointed COO Kevin Kuethe.

"Any time you grow at scale, more than 100 lights, it takes a few harvest cycles to 'fine tune' the operation. And fine tuning our custom concentrated nutrient blends is a key element in the process. After all, it is the nutrition that keeps the plants healthy, and each strain eats a little different blend of nutrients to maximize the genetic potential of each of our strains. Now the entire process is dialed in and we are operating our precision controlled growing environments for maximum consistency, quality and yield."

The GB Sciences cultivation facility has 180 active flower lights for plant cultivation. With an industry standard yield of approximately one and one half (1.5) pounds yield per flower light (of cured, untrimmed flower), and the current market rates per gram of cannabis in the Nevada market, it seems impossible to get this kind of recurring revenue from a cultivation facility of this size.

"Improbable, yes… but impossible, no," said Mr. Kuethe. "Our growing techniques have an intangible that we like to call: happiness. And by happiness, I'm referring to a feeling, a vibe, an intangible that we are all on the same mission and in the same direction to do better, to be better and you can see it in the way we work, and you can definitely see it in our plants. They are large, healthy, and produce consistently high yields. We do this by using state-of-the-art modern growing techniques to create and control the growing environment…yes. But inside that environment, our growers bring a deep experience and understanding of the plant, along with a truly happy vibe. That's how we get basically double the industry average yield. The plants pick up on that vibe and it shows all the way throughout their lives. And the numbers speak for themselves. We cultivate happy plants, and the happiness spreads to the dispensaries all the way down to the consumer. Call it crazy, but it's real. Our entire ecosystem is happy… like a room without a roof."

GB Sciences, Inc.
GB Sciences, Inc. (GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to:http://gbsciences.com



https://globenewswire.com/news-release/2017/11/13/1184975/0/en/GB-Sciences-is-Happy.html